Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
01 1Malladi Drugs & Pharmaceuticals Limited
02 1Supriya Lifescience Limited
03 1Fagron Inc
04 1KALCHEM INTERNATIONAL INC
05 1KREATIVE ORGANICS PRIVATE LIMITED
06 1Kongo Chemical Co., Ltd.
07 1LETCO MEDICAL, LLC
08 1Professional Compounding Centers of America
09 3SpecGx LLC
10 1Spectrum Laboratory Products, Inc.
11 1Srikem laboratories Pvt. Ltd.
01 1Acetaminophen Anhydrous Basis And Chlorpheniramine Maleate
02 3CHLORPHENIRAMINE MALEATE
03 1CHLORPHENIRAMINE POLISTIREX
04 7Chlorpheniramine Maleate
05 1Chlorpheniramine Polistirex
01 4India
02 3Ireland
03 1Japan
04 1Netherlands
05 3U.S.A
06 1United Kingdom
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
NDC Package Code : 57218-765
Start Marketing Date : 2017-04-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
NDC Package Code : 61281-3300
Start Marketing Date : 2013-11-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0137
Start Marketing Date : 1998-04-01
End Marketing Date : 2026-01-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 12294-9998
Start Marketing Date : 1978-01-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE
NDC Package Code : 0406-0117
Start Marketing Date : 2013-02-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (.9kg/kg .0055kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 0406-7480
Start Marketing Date : 2011-12-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.205kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 0406-8804
Start Marketing Date : 2013-12-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.115kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 51927-0247
Start Marketing Date : 2022-09-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-1980
Start Marketing Date : 1989-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 13746-116
Start Marketing Date : 2016-04-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Chlorpheniramine Maleate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chlorpheniramine Maleate, including repackagers and relabelers. The FDA regulates Chlorpheniramine Maleate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chlorpheniramine Maleate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chlorpheniramine Maleate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chlorpheniramine Maleate supplier is an individual or a company that provides Chlorpheniramine Maleate active pharmaceutical ingredient (API) or Chlorpheniramine Maleate finished formulations upon request. The Chlorpheniramine Maleate suppliers may include Chlorpheniramine Maleate API manufacturers, exporters, distributors and traders.
click here to find a list of Chlorpheniramine Maleate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Chlorpheniramine Maleate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Chlorpheniramine Maleate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Chlorpheniramine Maleate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Chlorpheniramine Maleate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Chlorpheniramine Maleate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Chlorpheniramine Maleate suppliers with NDC on PharmaCompass.
We have 11 companies offering Chlorpheniramine Maleate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
